Results 231 to 240 of about 83,214 (263)
Some of the next articles are maybe not open access.

.kappa. Opioid Receptor Selective Affinity Labels: Electrophilic Benzeneacetamides as .kappa.-Selective Opioid Antagonists

Journal of Medicinal Chemistry, 1994
2-(3,4-Dichlorophenyl)-N-methyl-N-[1-(3- or 4-substituted phenyl)-2-(1-pyrrolidinyl)ethyl]-acetamides 3-6 were synthesized as kappa-selective affinity labels and evaluated for opioid activity. In smooth muscle preparations, the non-electrophilic parent compound (+)-S-2 and the affinity labels 3-6 behaved as kappa agonists in that they were potently ...
A C, Chang   +4 more
openaire   +2 more sources

Novel opioid peptides as kappa opioid receptor antagonists

2006
Our laboratory is interested in identifying potent and selective peptide antagonists for opioid receptors and in exploring the structure-activity relationships for antagonist activity at these receptors. We have designed potential antagonists for receptors using the “message-address” concept [1] by combining small peptides with opioid antagonist ...
Jane V. Aldrich   +2 more
openaire   +1 more source

Delta and kappa opioid receptors in eyestalk ganglia of a crustacean

Brain Research, 1997
Crustacean eyestalk ganglia are part of the protocerebrum and have been demonstrated to produce numerous neurohormones. 3H(2-D-Pen, 5-D-Pen)-enkephalin, 3H-(-)-ethylketocyclazocine and 3H(D-Ala2-NMePhe-Glyol5)-enkephalin were used as ligands for opioid receptors on neuronal membrane preparations of eyestalk ganglia under consideration of their ...
J, Hanke   +3 more
openaire   +2 more sources

Potent and Selective Indolomorphinan Antagonists of the Kappa-Opioid Receptor

Journal of Medicinal Chemistry, 2000
The indole moiety in the delta-opioid antagonist, naltrindole (2, NTI), was employed as a scaffold to hold an "address" for interaction with the kappa-opioid receptor. The attachment of the address to the 5'-position of the indole moiety was based on superposition of NTI upon the kappa antagonist, norbinaltorphimine (1, norBNI).
W C, Stevens   +5 more
openaire   +2 more sources

The contribution of serotonin 1A receptors to kappa opioid immunosuppression

Neuroscience and Behavioral Physiology, 2009
Activation of kappa opioid receptors (kappa-OR) with the selective agonist rimorphin (0.1 mg/kg) produced marked suppression of the immune response in CBA mice. This effect was not seen on administration of rimorphin on the background of a reduction in the activity of the serotoninergic (5-HTergic) system resulting from stimulation of presynaptic (8-OH-
M A, Cheido, G V, Idova
openaire   +2 more sources

Molecular recognition at kappa opioid receptors

Pure and Applied Chemistry, 2001
Abstract Structure­activity relationships are rarely straightforward, and often are more complicated than they appear. For this reason, the use of site-directed mutagenesis as a complementary tool to analyze structure­activity relationships has been invaluable.
openaire   +1 more source

Kappa opioid receptors as modulators of novelty processing

Neuropsychopharmacology, 2023
Kathryn Braden, Daniel C. Castro
openaire   +2 more sources

Kappa-opioid receptors and analgesia.

Trends in pharmacological sciences, 1990
Over the past decade, opioids have attracted great attention. One important reason for this is the need for novel, strong analgesics free of the abuse potential and side-effects of narcotics such as morphine. Because morphine acts at mu-opioid receptors, efforts have been made to characterize analgesia mediated by non-mu sites, in particular kappa ...
openaire   +1 more source

Agonist-induced regulation and trafficking of $kappa; opioid receptors

Life Sciences, 2004
Chronic or repeated administration of kappa opioid agonists leads to tolerance to the subsequent drug administration. The mechanisms underlying tolerance are complex and changes at the receptor level contribute in part to the development of tolerance.
openaire   +2 more sources

Studies on Ligands of the Kappa Opioid Receptor

2016
This thesis is comprised of three parts. In the first part, we investigated zyklophin, a novel selective short-acting kappa opioid receptor (KOPR) antagonist, and its effects on scratching behaviors in Swiss-Webster mice. We investigated whether zyklophin was able to induce scratching in a dose-dependent fashion, and whether this scratching behavior ...
openaire   +1 more source

Home - About - Disclaimer - Privacy